Related Experiment Video
Updated: Aug 18, 2026

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
Thromboembolic pulmonary hypertension due to disseminated fibromuscular dysplasia
H Fukuhara1, H Kitayama, T Yokoyama
1Division of Pediatric Cardiology, Kinki University School of Medicine, 377-2, Ohno-Higashi, Osaka-Sayama, Osaka 589, Japan.
Abstract:
We present two patients with thromboembolic pulmonary hypertension associated with unusual complications probably caused by disseminated fibromuscular dysplasia (FMD) or FMD-like vascular lesions. Intimal fibroplasia, which is typical of the vascular lesions associated with FMD, was observed in both patients. The presence of such intimal lesions suggests that there was a systemic factor that caused the formation of recurrent thrombi in the systemic vessels in these patients. These cases are the first ones reported in which an association between FMD and pulmonary hypertension has been observed. The pathogenesis of the thrombi in our patients was thought to be recurrent pulmonary thromboembolisms resulting from FMD.
Insights
This study reports two cases of pulmonary hypertension linked to fibromuscular dysplasia (FMD), a rare vascular condition. The findings suggest FMD may cause recurrent blood clots, leading to this serious lung complication.
Area of Science:
- Cardiovascular Medicine
- Vascular Biology
- Pulmonary Hypertension Research
Background:
- Pulmonary hypertension is a severe condition affecting lung arteries.
- Fibromuscular dysplasia (FMD) is a rare vascular disease characterized by abnormal cell growth in artery walls.
- The link between FMD and pulmonary hypertension is not well-established.
Observation:
- Two patients presented with thromboembolic pulmonary hypertension.
- Both patients exhibited intimal fibroplasia, a hallmark of FMD.
- Unusual vascular complications were noted, potentially related to disseminated FMD.
Findings:
- The study observed a novel association between fibromuscular dysplasia and pulmonary hypertension.
- Intimal fibroplasia in systemic vessels suggests a potential underlying systemic factor.
- Recurrent pulmonary thromboembolisms, stemming from FMD, are hypothesized as the cause of pulmonary hypertension in these patients.
Implications:
- These findings highlight a potential new cause of pulmonary hypertension.
- Early recognition of FMD may be crucial in patients with unexplained thromboembolic events.
- Further research is needed to elucidate the precise mechanisms linking FMD to pulmonary hypertension and thromboembolism.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pulmonary Embolism I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism I: Introduction

